Olga Salamero
9PUBLICATIONS
58CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jan 11, 2025
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.Guadalupe Oñate, Ana Garrido, Montserrat Arnan
|May 05, 2023
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.Guadalupe Oñate, Marta Pratcorona, Ana Garrido
|Jun 01, 2022
Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan.Francesca Guijarro, Alex Bataller, Marina Diaz-Beyá
|Dec 31, 2021
Prognostic impact of micromegakaryocytes in primary myelodysplastic syndromes.Sílvia Saumell, Miranda Fernández-Serrano, Alba Mesa
|Oct 14, 2020
First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia.Olga Salamero, Pau Montesinos, Christophe Willekens
Pageof 2
Frequent Collaborators
3 joint publications
Jorge Sierra
3 joint publications
Antònia Sampol
3 joint publications
Mar Tormo
3 joint publications
Jordi Esteve
3 joint publications
Pau Montesinos
2 joint publications
David Martínez-Cuadrón
2 joint publications
Francisca Guijarro
2 joint publications
Juan Carlos Hernandez-Boluda
2 joint publications
Francesc Bosch
2 joint publications
Alex Bataller
